CAR-T CD19
/ Sheba Medical Center
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 28, 2023
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
(clinicaltrials.gov)
- P2/3 | N=10 | Recruiting | Sponsor: Sheba Medical Center | Trial completion date: Dec 2023 ➔ Dec 2024
Trial completion date • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
August 07, 2020
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
(clinicaltrials.gov)
- P2/3; N=10; Recruiting; Sponsor: Sheba Medical Center; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • IO Biomarker • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
February 05, 2020
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
(clinicaltrials.gov)
- P2/3; N=10; Not yet recruiting; Sponsor: Sheba Medical Center
Clinical • IO Biomarker • New P2/3 trial
1 to 3
Of
3
Go to page
1